KYLYS AESTHETICS offers a biocompatible hyaluronan-based and thermosensitive dermal filler (Medical Device Class III) that has the ability to form microgel structures in the tissue, resulting in a long-lasting effect and no migration from the injection site. Our patented technology allows for injection with an ultra-thin 34G needle, resulting in greater precision, less pain for the patient, and fewer hematomas. With our cutting-edge technology and commitment to research and development, we aim to revolutionize the market of skin filling.
We recently completed all preclinical testing, including biocompatibility, and are now preparing for our 1st pilot clinical trial scheduled for August 2024. With the initial clinical data in hand, we will initiate our Series A with the right partner.
We recently completed all preclinical testing, including biocompatibility, and are now preparing for our 1st pilot clinical trial scheduled for August 2024. With the initial clinical data in hand, we will initiate our Series A with the right partner.
Location: Switzerland, Geneva, Arare
Total raised: $1.23M
Investors 2
| Date | Name | Website |
| 05.03.2024 | Venture Ki... | venturekic... |
| 25.03.2024 | VentureLab | venturelab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.06.2025 | - | $1.23M | - |
Mentions in press and media 7
| Date | Title | Description |
| 23.06.2025 | KYLYS Aesthetics secures CHF 1 M to advance next-gen hyaluronic acid medical devices | KYLYS Aesthetics develops innovative injectable products designed for soft tissue regeneration and rejuvenation. Its flagship device, created with the University of Geneva, aims to deliver safer and longer-lasting results. The CHF 1 Million... |
| 23.06.2025 | CHF 1 million to advance KYLYS next-gen hyaluronic acid medical devices | Founded in Geneva, KYLYS AESTHETICS SA is at the forefront of regenerative aesthetic medicine. With a pipeline of advanced hyaluronic acid-based medical devices and cosmeceutical products, the company is committed to improving patient outc... |
| 27.03.2024 | Ten startups on a business voyage in Boston | Selected from over 70 applications by a jury of investors and biotech experts, the ten startups selected for the 18th edition of Venture Leaders Biotech will join the roadshow in Boston, one of the world's most important life science hubs.... |
| 16.05.2023 | FIF supports Fluosphera, Kylys Aesthetics and Consulto | |
| 09.11.2021 | The AIT India digital edition kicks off | |
| 02.11.2021 | Startups recycling composites into reusable fibers, developing multi-tissue test systems, highly-effective biomolecules, and a cloud-based platform for medical researchers each win CHF 10.000 | Composite Recycling: Recycling Composites Into Reusable Fibers Every year in Europe, around 100000 boats reach the end of their life. Until now the industry did not have a solution to recycle the glass fibers in a cost-effective way so the ... |
| - | KYLYS | “KYLYS – Biomolecules now, for your future” |